Therefore, we sought to investigate the role of EBV particles, irrespective of viral replication, on colitis severity and the involvement of TLR9 inhibition in ameliorating intestinal inflammation in an IBD mouse model. This evidence concerns the gene TLR9 and inflammatory bowel disease.